UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

YB-1 Expression and Phosphorylation Regulate Tumorigenicity and Invasiveness in Melanoma by Influencing EMT

Molecular cancer research, 2018-07, Vol.16 (7), p.1149-1160

2018

Volltextzugriff (PDF)

Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibition

Cell death & disease, 2020-07, Vol.11 (7), p.581, Article 581

2020

Volltextzugriff (PDF)

BRAF Inhibitors Amplify the Proapoptotic Activity of MEK Inhibitors by Inducing ER Stress in NRAS-Mutant Melanoma

Clinical cancer research, 2017-10, Vol.23 (20), p.6203-6214

2017

Volltextzugriff (PDF)

Loss of p14 diminishes immunogenicity in melanoma via non‐canonical Wnt signaling by reducing the peptide surface density

Molecular oncology, 2024-10, Vol.18 (10), p.2449-2470

2024

Volltextzugriff (PDF)

Inhibition of p90 ribosomal S6 kinases disrupts melanoma cell growth and immune evasion

Journal of experimental & clinical cancer research, 2023-07, Vol.42 (1), p.175-175, Article 175

2023

Volltextzugriff (PDF)

Single-cell trajectories of melanoma cell resistance to targeted treatment

Cancer biology & medicine, 2022-01, Vol.19 (1), p.56-73

2022

Volltextzugriff (PDF)

MALT1 Protease Activity Controls the Expression of Inflammatory Genes in Keratinocytes upon Zymosan Stimulation

Journal of investigative dermatology, 2016-04, Vol.136 (4), p.788-797

2016

Volltextzugriff (PDF)

Biomechanical and biochemical assessment of YB-1 expression in A375 melanoma cell line: Exploratory study

Frontiers in Molecular Medicine, 2023-04, Vol.3, p.1050487

2023

Volltextzugriff (PDF)

Combined activity of temozolomide and the mTOR inhibitor temsirolimus in metastatic melanoma involves DKK1

Experimental dermatology, 2017-07, Vol.26 (7), p.598-606

2017

Volltextzugriff (PDF)

Uropathogenic Escherichia coli Isolates from Pregnant Women in Different Countries

Journal of Clinical Microbiology, 2012-11, Vol.50 (11), p.3569-3574

2012

Volltextzugriff (PDF)

Y-box binding protein 1 – A prognostic marker and target in tumour therapy

European journal of cell biology, 2014-01, Vol.93 (1-2), p.61-70

2014

Volltextzugriff (PDF)

Targeting the Y-box Binding Protein-1 Axis to Overcome Radiochemotherapy Resistance in Solid Tumors

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (4), p.1072-1087

2021

Volltextzugriff (PDF)

Targeting the Y-box Binding Protein-1 Axis to Overcome Radiochemotherapy Resistance in Solid Tumors

International journal of radiation oncology, biology, physics, 2022-03, Vol.111 (4)

2022

Volltextzugriff (PDF)

7 Fragen an Dr. Corinna Kosnopfel

Kompass Onkologie, 2021-06, Vol.8 (2), p.95-96

Kosnopfel, Corinna

2021

Volltextzugriff (PDF)

7 Fragen an Dr. Corinna Kosnopfel

Karger Kompass Dermatologie, 2020-08, Vol.8 (3), p.130-131

Kosnopfel, Corinna

2020

Volltextzugriff (PDF)

mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphoma

Leukemia, 2023-01, Vol.37 (1), p.178-189

2023

Volltextzugriff (PDF)

Exploring the In Vitro and In Vivo Therapeutic Potential of BRAF and MEK Inhibitor Combination in NRAS-Mutated Melanoma

Cancers, 2023-11, Vol.15 (23), p.5521

2023

Volltextzugriff (PDF)

Expression of DNA Methyltransferase 1 Is a Hallmark of Melanoma, Correlating with Proliferation and Response to B-Raf and Mitogen-Activated Protein Kinase Inhibition in Melanocytic Tumors

The American journal of pathology, 2020-10, Vol.190 (10), p.2155-2164

2020

Volltextzugriff (PDF)

Melanoma cells resistant towards MAPK inhibitors exhibit reduced TAp73 expression mediating enhanced sensitivity to platinum-based drugs

Cell death & disease, 2018-09, Vol.9 (9), p.930-13, Article 930

2018

Volltextzugriff (PDF)

Tumour Progression Stage-Dependent Secretion of YB-1 Stimulates Melanoma Cell Migration and Invasion

Cancers, 2020-08, Vol.12 (8), p.2328

2020

Volltextzugriff (PDF)

Blood Eosinophils Are Associated with Efficacy of Targeted Therapy in Patients with Advanced Melanoma

Cancers, 2022-05, Vol.14 (9), p.2294

2022

Volltextzugriff (PDF)

Human melanoma cells resistant to MAPK inhibitors can be effectively targeted by inhibition of the p90 ribosomal S6 kinase

Oncotarget, 2017-05, Vol.8 (22), p.35761-35775

2017

Volltextzugriff (PDF)

Susceptibility of Melanoma Cells to Targeted Therapy Correlates with Protection by Blood Neutrophils

Cancers, 2024-05, Vol.16 (9), p.1767

2024

Volltextzugriff (PDF)

Blocking Y-Box Binding Protein-1 through Simultaneous Targeting of PI3K and MAPK in Triple Negative Breast Cancers

Cancers, 2020-10, Vol.12 (10), p.2795

2020

Volltextzugriff (PDF)

46th annual congress of the “Arbeitsgemeinschaft Dermatologische Forschung” in Munich, Germany

Experimental dermatology, 2019-09, Vol.28 (9), p.1094-1099

2019

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(21)
Science & Technology
(21)
Melanoma
(14)
Oncology
(13)
Humans
(12)
Cell Culture
(10)
Cell Line, Tumor
(9)
Metastases
(8)
Metastasis
(8)
Skin Cancer
(8)
Cell Cycle
(7)
Kinases
(7)
Apoptosis
(6)
Cancer
(6)
Melanoma - Pathology
(6)
Cell Biology
(5)
Dermatology
(5)
Map Kinase
(5)
Protein Kinase Inhibitors - Pharmacology
(5)
Proteins
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

YB-1 Expression and Phosphorylation Regulate Tumorigenicity and Invasiveness in Melanoma by Influencing EMT

Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibition

BRAF Inhibitors Amplify the Proapoptotic Activity of MEK Inhibitors by Inducing ER Stress in NRAS-Mutant Melanoma

Loss of p14 diminishes immunogenicity in melanoma via non‐canonical Wnt signaling by reducing the peptide surface density

Inhibition of p90 ribosomal S6 kinases disrupts melanoma cell growth and immune evasion

Single-cell trajectories of melanoma cell resistance to targeted treatment

MALT1 Protease Activity Controls the Expression of Inflammatory Genes in Keratinocytes upon Zymosan Stimulation

Biomechanical and biochemical assessment of YB-1 expression in A375 melanoma cell line: Exploratory study

Combined activity of temozolomide and the mTOR inhibitor temsirolimus in metastatic melanoma involves DKK1

Uropathogenic Escherichia coli Isolates from Pregnant Women in Different Countries

Y-box binding protein 1 – A prognostic marker and target in tumour therapy

Targeting the Y-box Binding Protein-1 Axis to Overcome Radiochemotherapy Resistance in Solid Tumors

Targeting the Y-box Binding Protein-1 Axis to Overcome Radiochemotherapy Resistance in Solid Tumors

7 Fragen an Dr. Corinna Kosnopfel

7 Fragen an Dr. Corinna Kosnopfel

mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphoma

Exploring the In Vitro and In Vivo Therapeutic Potential of BRAF and MEK Inhibitor Combination in NRAS-Mutated Melanoma

Expression of DNA Methyltransferase 1 Is a Hallmark of Melanoma, Correlating with Proliferation and Response to B-Raf and Mitogen-Activated Protein Kinase Inhibition in Melanocytic Tumors

Melanoma cells resistant towards MAPK inhibitors exhibit reduced TAp73 expression mediating enhanced sensitivity to platinum-based drugs

Tumour Progression Stage-Dependent Secretion of YB-1 Stimulates Melanoma Cell Migration and Invasion

Blood Eosinophils Are Associated with Efficacy of Targeted Therapy in Patients with Advanced Melanoma

Human melanoma cells resistant to MAPK inhibitors can be effectively targeted by inhibition of the p90 ribosomal S6 kinase

Susceptibility of Melanoma Cells to Targeted Therapy Correlates with Protection by Blood Neutrophils

Blocking Y-Box Binding Protein-1 through Simultaneous Targeting of PI3K and MAPK in Triple Negative Breast Cancers

46th annual congress of the “Arbeitsgemeinschaft Dermatologische Forschung” in Munich, Germany

Suchergebnisse filtern